Beachbody Co., Inc. Class A BODI 深 沪
已收盘 07-02 16:00:00 美东时间
10.79
+0.680
+6.73%
华盛通- 最 高10.82
- 今 开10.26
- 成交量 5.42万股
- 最 低 10.14
- 昨 收 10.11
- 总市值 7813.86万
- 52周最高 16.87
- 市盈率 静 --
- 换手率 0.75%
- 52周最低 3.76
- 委 比 29.90%
- 总股本 724.18万
- 历史最高 910.00
- 量 比 2.27
- 振 幅 6.73%
- 历史最低 3.3812
- 每 手 1
- 风险率 3.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Beachbody Co Q1 2026 Earnings Call: Complete Transcript
Beachbody Co (NYSE:BODI) held its first-quarter earnings conference call on Tue...
05-13 06:33
Beachbody Co Sees Q2 Sales $46.000M-$51.000M vs $53.490M Est
Beachbody Co (NYSE:BODI) sees Q2 sales of $46.000 million-$51.000 million vs $53.490 million analyst estimate.
05-13 04:09
The Beachbody Company, Inc. Class A Common Stock Q1 Adj. EPS $0.33 Beats $(0.17) Estimate, Sales $54.284M Beat $51.628M Estimate
The Beachbody Company, Inc. Class A Common Stock (NYSE:BODI) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $(0.17) by 294.12 percent. This is a 139.29 percent increase over
05-13 04:08
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
Canaccord Genuity Maintains Buy on Beachbody Co, Raises Price Target to $19
Canaccord Genuity analyst Susan Anderson maintains Beachbody Co (NASDAQ:BODI) with a Buy and raises the price target from $15 to $19.
05-06 02:45
Shares of companies within the broader consumer discretionary sector are trading higher amid overall market strength after Iran opened the Strait of Hormuz for the remainder of the ceasefire following a 10-day armistice between Israel and Lebanon. This alleviates the ongoing supply disruption and lessens energy costs.
Shares of companies within the broader consumer discretionary sector are tradin...
04-18 01:13
Shares of companies within the broader consumer discretionary sector are trading lower as spiking energy costs and inflation may limit nonessential spending.
Shares of companies within the broader consumer discretionary sector are tradin...
03-28 03:41
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
美股大行评级 | 潜在涨幅467.73%！Corbus制药控股获Oppenheimer升目标价至57美元，维持"跑赢大市"评级
今日重点评级关注：Oppenheimer：维持Corbus制药控股"跑赢大市"评级，目标价从53美元升至57美元；Canaccord Genuity：维持WAVE Life Sciences"买入"评级，目标价从43美元升至52美元
03-11 12:40
